Company intelligence / Profile preview

Green Isle Capital

Ownership: Private
Development stage: Other

Overview

Green Isle Capital is a Puerto Rico-based private equity fund established in 2015. It focuses on investments primarily within Puerto Rico and helps clients leverage tax benefits available through Puerto Rico’s Law 185 and Act 60. The fund has been involved in over $150 million in transactions[1]. There is no evidence that it operates in the life sciences, biotech, pharma, or healthcare sectors.

Industry: Investors

Beyond the preview

Go deeper on Green Isle Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Green Isle Capital.

Explore the full profile